Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

R&D Market Pulse: GDP Growth May Slow in Third Quarter

By R&D Editors | July 30, 2018

The R&D Index for the week ending July 27, 2018 closed at 4,658.00 for the 25 companies in the R&D Index. The Index was up 1.80% (or 82.31 basis points) from the week ending July 20, 2018. Twenty R&D Index companies gained value last week from 0.20% (Amazon) to 9.19% (Eli Lilly). Five R&D Index companies lost value last week from -0.24% (Apple Computer) to -8.15% (Intel).

The U.S. Dept. of Commerce reported on Friday that the U.S. economy grew at a seasonally adjusted rate of 4.1% in 2Q, the largest growth period since 3Q 2014. Even when adjusting for trade events, the overall growth rate still exceeds 4%, according to analysts. The Federal Reserve is expected to maintain its current short-term interest rates at its regularly scheduled meeting on August 1, but raise rates to a range between 2.0% and 2.25% at its meeting in September for its third increase in 2018. Analysts expect the strong growth seen over the past several quarters to cool as consumer spending slows as the boost seen from the tax cuts fades.

R&D Index member Qualcomm stated last week that it has ceased its plans to purchase for $44 billion Dutch semiconductor maker NXP, following its failure to obtain Chinese regulatory approval. The trade tensions between the U.S. and China likely became a sticking point in the negotiations. Qualcomm stock rose following the announcement and closed at 7% up for the week. Qualcomm is scheduled to spend $4.95 billion on R&D in 2019, down 4.4% from its $5.18 billion invested in 2018. NXP is expected to spend $2.24 billion on R&D in 2019, up more than 15% from its R&D spending in 2018.

R&D member Intel lost an appeals court ruling with the Internal Revenue Service concerning how companies divide expenses between their domestic and foreign operations. Intel is considering its options for further judicial review. Intel stock slid more than 8% for the week as a result.

R&D Index member General Motors, along with Ford Motor and Fiat Chrysler all lowered their 2018 operating profits last week by more than 10% each primarily due to the 15% to 25% tariffs imposed on imported steel and aluminum products. Sales in China was also cited as a contributing factor for the lower profits as China has imposed retaliatory tariffs on U.S. auto exports. Their lower profits this year are expected to have a subsequent effect on their R&D spending capabilities for 2019. These ‘big three’ auto firms plan to spend a combined $19.7 billion in R&D in 2018 and were expected to increase those amounts by about 3% in 2019 to a combined total of $20.3 billion.

R&D Index Week Ending July 27, 2018

  Ticker Exchange 2018 R&D millions U.S. $ 07/20/18 07/27/18 7/27/18 to 7/20/18 7/27/18 to 12/29/17
Amazon AMZN NASDAQ 26,750 1,813.70 1,817.27 0.20% 55.39%
Alphabet/Google GOOGL NASDAQ 18,796 1,184.91 1,238.50 4.52% 17.57%
Apple AAPL NASDAQ 14,037 191.44 190.98 -0.24% 12.85%
Intel INTC NASDAQ 13,702 51.91 47.68 -8.15% 3.29%
Microsoft MSFT NASDAQ 13,558 106.27 107.68 1.33% 25.88%
Roche Pharm RHHBY OTC 12,284 29.47 30.60 3.83% -3.10%
Johnson & Johnson JNJ NYSE 11,493 125.85 131.55 4.53% -5.84%
Merck & Co. MRK NYSE 11,323 62.52 63.49 1.55% 12.83%
Volkswagen AG VLKAY OTC 10,915 33.45 34.27 2.45% -15.26%
Toyota TM NYSE 10,848 131.80 134.46 2.02% 5.73%
Novartis NVS NYSE 8,934 82.27 83.49 1.48% -0.56%
Honda HMC NYSE 8,180 29.19 30.33 3.91% -11.00%
Pfizer PFE NYSE 7,942 37.33 38.41 2.89% 6.05%
Daimler DDAIY OTC 7,615 67.13 68.81 2.50% -18.63%
General Motors GM NYSE 7,278 39.40 37.53 -4.75% -8.44%
Oracle ORCL NYSE 7,001 48.52 48.63 0.23% 2.86%
Bristol-Myers Squibb BMY NYSE 6,981 56.71 56.92 0.37% -7.11%
Eli Lilly Co LLY NYSE 6,769 88.47 96.60 9.19% 14.37%
GlaxoSmithKline GSK NYSE 6,394 41.87 40.76 -2.65% 14.91%
Cisco CSCO NASDAQ 6,009 42.01 42.57 1.33% 11.15%
IBM IBM NYSE 5,842 146.35 145.15 -0.82% -5.39%
Bayer AG BAYN OTC 5,743 26.99 28.03 3.85% -9.84%
Astra Zeneca PLC AZN NYSE 5,483 37.17 38.23 2.85% 10.17%
Qualcomm QCOM NASDAQ 5,183 58.61 62.69 6.96% -2.08%
Sanofi SA SNY NYSE 4,694 42.35 43.37 2.41% 0.86%
Total     243,754 4,575.69 4,658.00 1.80% 22.84%
               
    Biopharmaceutical   631.00 651.45 3.24% 2.15%
    Automotive   300.97 305.40 1.47% -6.67%
    ICT   1,830.02 1,883.88 2.94% 13.67%

About the R&D Index

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2017 were selected based on the latest listings from Schonfeld & Associates’ June 2018 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT (8) and conglomerate (1) organizations who invested a cumulative total of more than $209 billion in R&D in 2017, or approximately 10% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2018 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

The companies used in the R&D Index include Amazon, Alphabet/Google, Microsoft, Intel, Apple, Volkswagen AG, Roche Pharma, Toyota, Johnson & Johnson, Novartis, General Motors, Pfizer, Bristol-Myers Squibb, Cisco, Qualcomm, Oracle, Honda Motor Company, Astra Zeneca plc, Merck & Company, Daimler, Bayer AG, Sanofi SA, IBM, GlaxoSmithKline and Eli Lilly Co. Stock prices are based on those stocks traded on the U.S. exchanges. R&D Index trends (in the stock prices) are just one indicator of the amount of capital available to these high-technology companies to invest in R&D and should not be implied to indicate the absolute value of R&D investments made by these organizations. The companies chosen for the R&D Index have very large sophisticated internal and global R&D organizations with each company investing between $4.5 and $17 billion annually on their R&D efforts.

Related Articles Read More >

5 R&D developments to keep an eye on this week: Solar crash and Trump’s energy pivot meets Musk’s rebellion
Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
7 major R&D developments this week: Tariff uncertainty persists, Pfizer sells campus, Scania acquires Northvolt unit
economic crisis stock chart falling down business global money bankruptcy concept
7 major R&D developments this week: Tariffs roil markets, MIT wins $12B contract, Siemens plans $5B acquisition
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE